383 related articles for article (PubMed ID: 31518516)
1. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
[TBL] [Abstract][Full Text] [Related]
2. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
[TBL] [Abstract][Full Text] [Related]
4. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study.
Ng TKS; Coughlan C; Heyn PC; Tagawa A; Carollo JJ; Kua EH; Mahendran R
Aging (Albany NY); 2021 Oct; 13(19):22666-22689. PubMed ID: 34607976
[TBL] [Abstract][Full Text] [Related]
6. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
7. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.
Angelucci F; Spalletta G; di Iulio F; Ciaramella A; Salani F; Colantoni L; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Bossù P
Curr Alzheimer Res; 2010 Feb; 7(1):15-20. PubMed ID: 20205668
[TBL] [Abstract][Full Text] [Related]
9. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise increases peripheral brain-derived neurotrophic factors in patients with cognitive impairment: A meta-analysis.
Huang H; Li W; Qin Z; Shen H; Li X; Wang W
Restor Neurol Neurosci; 2021; 39(3):159-171. PubMed ID: 33998558
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment and BDNF serum levels.
Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
[TBL] [Abstract][Full Text] [Related]
12. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
13. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
Voigt RM; Raeisi S; Yang J; Leurgans S; Forsyth CB; Buchman AS; Bennett DA; Keshavarzian A
PLoS One; 2021; 16(3):e0240342. PubMed ID: 33661922
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
15. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E ϵ4 genotype.
Wang C; Cui Y; Yang J; Zhang J; Yuan D; Wei Y; Li Y; Duo Y; Li S; Zhu W; Zheng L
Biomarkers; 2015 Feb; 20(1):84-8. PubMed ID: 25532446
[TBL] [Abstract][Full Text] [Related]
16. Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Du Y; Wu HT; Qin XY; Cao C; Liu Y; Cao ZZ; Cheng Y
J Mol Neurosci; 2018 Jul; 65(3):289-300. PubMed ID: 29956088
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia.
Nikolac Perkovic M; Borovecki F; Filipcic I; Vuic B; Milos T; Nedic Erjavec G; Konjevod M; Tudor L; Mimica N; Uzun S; Kozumplik O; Svob Strac D; Pivac N
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979505
[TBL] [Abstract][Full Text] [Related]
18. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
[TBL] [Abstract][Full Text] [Related]
19. Association of Serum Manganese Levels with Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
Du K; Liu M; Pan Y; Zhong X; Wei M
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273828
[TBL] [Abstract][Full Text] [Related]
20. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
